Related Experiment Video
Updated: Feb 7, 2026

Author Spotlight: Enhancing Diagnostic Strategies and Biomarker Development for Comprehensive Lung Function Analysis
Published on: August 9, 2024
Biomarkers in Interstitial lung diseases.
Nadia Nathan1, Harriet Corvol2, Serge Amselem3
1Assistance Publique-Hopitaux de Paris (AP-HP), Hôpital Trousseau, Service de pneumologie pédiatrique; Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris06; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR_S 933; Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris06.
Interstitial lung diseases (ILDs) are rare, chronic respiratory disorders. This review explores blood biomarkers for diagnosing, managing, and tracking ILD progression, especially in children.
Area of Science:
- Pulmonology
- Biomarker Research
- Pediatric Respiratory Medicine
Background:
- Interstitial lung diseases (ILDs) are rare, chronic respiratory disorders with high morbidity and mortality.
- Pediatric ILDs are often underdiagnosed and challenging to manage.
- Effective biomarkers are crucial for ILD diagnosis, severity assessment, and treatment monitoring.
Purpose of the Study:
- To review current knowledge on blood biomarkers for ILD patient management.
- To highlight molecular parameters relevant to ILD diagnosis and progression.
- To address the challenge of biomarker identification in ILD research.
Main Methods:
- Literature review focused on blood-based biomarkers for ILDs.
- Analysis of molecular parameters relevant to ILD clinical practice.
- Synthesis of current information on biomarker utility in ILD.
Main Results:
- Blood biomarkers show potential for ILD diagnosis and management.
- Specific molecular parameters are under investigation for their role in ILD.
- Further research is needed to validate biomarkers for clinical application.
Conclusions:
- Blood biomarkers represent a promising avenue for improving ILD patient care.
- Identifying reliable biomarkers is essential for advancing ILD translational research.
- This review provides an overview of key blood biomarkers for ILD management.
Related Concept Videos
Lung Capacity
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Pleura of the Lungs
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Gross Anatomy of the Lungs
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

